队列简介：血液恶性肿瘤研究网络（HMRN）：一个基于英国人群的患者队列。 - Suppr

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

作者信息

Smith Alexandra, Howell Debra, Crouch Simon, Painter Dan, Blase John, Wang Han-I, Hewison Ann, Bagguley Timothy, Appleton Simon, Kinsey Sally, Burton Cathy, Patmore Russell, Roman Eve

机构信息

Department of Health Sciences, University of York, York, UK.

Paediatric Haematology and Oncology Unit, Leeds General Infirmary.

出版信息

Int J Epidemiol. 2018 Jun 1;47(3):700-700g. doi: 10.1093/ije/dyy044.

DOI:10.1093/ije/dyy044

PMID:29618056

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6005016/

Abstract

摘要

相似文献

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

Int J Epidemiol. 2018 Jun 1;47(3):700-700g. doi: 10.1093/ije/dyy044.

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.

Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275.

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.

Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1.

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).

Cancer Causes Control. 2016 Aug;27(8):1019-26. doi: 10.1007/s10552-016-0780-z. Epub 2016 Jun 28.

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.

Value Health. 2018 Oct;21(10):1176-1185. doi: 10.1016/j.jval.2018.03.007. Epub 2018 Apr 24.

Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model.

Value Health. 2014 Mar;17(2):205-14. doi: 10.1016/j.jval.2013.12.007.

Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.

Ann Hematol. 2009 Aug;88(8):761-7. doi: 10.1007/s00277-008-0662-x. Epub 2008 Dec 16.

How many patients with haematological malignancy need the facilities offered by a district general hospital?

J Public Health Med. 2002 Sep;24(3):196-9. doi: 10.1093/pubmed/24.3.196.

Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy.

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12956. doi: 10.1111/ecc.12956. Epub 2018 Oct 25.

Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.

Acta Oncol. 2015 May;54(5):743-9. doi: 10.3109/0284186X.2014.999871. Epub 2015 Mar 9.

引用本文的文献

Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research Network.

Haematologica. 2025 Sep 1;110(9):2203-2208. doi: 10.3324/haematol.2024.287095. Epub 2025 Mar 20.

A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study.

Front Oncol. 2024 Dec 5;14:1472551. doi: 10.3389/fonc.2024.1472551. eCollection 2024.

Information preferences of patients with chronic blood cancer: A qualitative investigation.

PLoS One. 2024 Aug 20;19(8):e0293772. doi: 10.1371/journal.pone.0293772. eCollection 2024.

The National Swedish Lymphoma Register - a systematic validation of data quality.

Acta Oncol. 2024 Jul 10;63:563-572. doi: 10.2340/1651-226X.2024.40431.

Genetically determined telomere length as a risk factor for hematological malignancies: evidence from Mendelian randomization analysis.

Aging (Albany NY). 2024 Mar 6;16(5):4684-4698. doi: 10.18632/aging.205625.

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.

Blood Adv. 2024 Jan 23;8(2):296-308. doi: 10.1182/bloodadvances.2023010798.

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Hemasphere. 2023 Apr 5;7(4):e863. doi: 10.1097/HS9.0000000000000863. eCollection 2023 Apr.

Provision and delivery of survivorship care for adult patients with haematological malignancies: A scoping review protocol.

PLoS One. 2023 Mar 2;18(3):e0282458. doi: 10.1371/journal.pone.0282458. eCollection 2023.

Clinicopathological Spectrum of B-Cell Non-Hodgkin Lymphoma in Pakistan Population: A Single-Center Study.

Cureus. 2023 Jan 28;15(1):e34298. doi: 10.7759/cureus.34298. eCollection 2023 Jan.

SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.

Mol Cancer. 2023 Feb 21;22(1):39. doi: 10.1186/s12943-023-01736-8.

本文引用的文献

Determinants of hospital death in haematological cancers: findings from a qualitative study.

BMJ Support Palliat Care. 2018 Mar;8(1):78-86. doi: 10.1136/bmjspcare-2016-001289. Epub 2017 Jun 29.

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.

Eur J Cancer. 2017 Jun;78:53-60. doi: 10.1016/j.ejca.2017.03.013. Epub 2017 Apr 13.

Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.

Br J Haematol. 2017 Apr;177(1):67-71. doi: 10.1111/bjh.14513. Epub 2017 Feb 1.

Phase-specific and lifetime costs of cancer care in Ontario, Canada.

BMC Cancer. 2016 Oct 18;16(1):809. doi: 10.1186/s12885-016-2835-7.

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.

Cancer Epidemiol. 2016 Jun;42:186-98. doi: 10.1016/j.canep.2016.03.011. Epub 2016 Apr 16.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.

Eur J Health Econ. 2017 Mar;18(2):255-267. doi: 10.1007/s10198-016-0775-4. Epub 2016 Mar 11.

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma.

Cancer Epidemiol. 2015 Dec;39(6):1103-12. doi: 10.1016/j.canep.2015.08.015. Epub 2015 Sep 2.

Preferred and actual place of death in haematological malignancy.

BMJ Support Palliat Care. 2017 Jun;7(2):150-157. doi: 10.1136/bmjspcare-2014-000793. Epub 2015 Jul 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

作者信息

Smith Alexandra, Howell Debra, Crouch Simon, Painter Dan, Blase John, Wang Han-I, Hewison Ann, Bagguley Timothy, Appleton Simon, Kinsey Sally, Burton Cathy, Patmore Russell, Roman Eve

机构信息

Department of Health Sciences, University of York, York, UK.

Paediatric Haematology and Oncology Unit, Leeds General Infirmary.

出版信息

Int J Epidemiol. 2018 Jun 1;47(3):700-700g. doi: 10.1093/ije/dyy044.

DOI:10.1093/ije/dyy044

PMID:29618056

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6005016/

Abstract

摘要

相似文献

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

Int J Epidemiol. 2018 Jun 1;47(3):700-700g. doi: 10.1093/ije/dyy044.

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.

Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275.

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.

Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1.

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).

Cancer Causes Control. 2016 Aug;27(8):1019-26. doi: 10.1007/s10552-016-0780-z. Epub 2016 Jun 28.

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.

Value Health. 2018 Oct;21(10):1176-1185. doi: 10.1016/j.jval.2018.03.007. Epub 2018 Apr 24.

Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model.

Value Health. 2014 Mar;17(2):205-14. doi: 10.1016/j.jval.2013.12.007.

Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.

Ann Hematol. 2009 Aug;88(8):761-7. doi: 10.1007/s00277-008-0662-x. Epub 2008 Dec 16.

How many patients with haematological malignancy need the facilities offered by a district general hospital?

J Public Health Med. 2002 Sep;24(3):196-9. doi: 10.1093/pubmed/24.3.196.

Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy.

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12956. doi: 10.1111/ecc.12956. Epub 2018 Oct 25.

Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.

Acta Oncol. 2015 May;54(5):743-9. doi: 10.3109/0284186X.2014.999871. Epub 2015 Mar 9.

引用本文的文献

Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research Network.

Haematologica. 2025 Sep 1;110(9):2203-2208. doi: 10.3324/haematol.2024.287095. Epub 2025 Mar 20.

A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study.

Front Oncol. 2024 Dec 5;14:1472551. doi: 10.3389/fonc.2024.1472551. eCollection 2024.

Information preferences of patients with chronic blood cancer: A qualitative investigation.

PLoS One. 2024 Aug 20;19(8):e0293772. doi: 10.1371/journal.pone.0293772. eCollection 2024.

The National Swedish Lymphoma Register - a systematic validation of data quality.

Acta Oncol. 2024 Jul 10;63:563-572. doi: 10.2340/1651-226X.2024.40431.

Genetically determined telomere length as a risk factor for hematological malignancies: evidence from Mendelian randomization analysis.

Aging (Albany NY). 2024 Mar 6;16(5):4684-4698. doi: 10.18632/aging.205625.

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.

Blood Adv. 2024 Jan 23;8(2):296-308. doi: 10.1182/bloodadvances.2023010798.

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Hemasphere. 2023 Apr 5;7(4):e863. doi: 10.1097/HS9.0000000000000863. eCollection 2023 Apr.

Provision and delivery of survivorship care for adult patients with haematological malignancies: A scoping review protocol.

PLoS One. 2023 Mar 2;18(3):e0282458. doi: 10.1371/journal.pone.0282458. eCollection 2023.

Clinicopathological Spectrum of B-Cell Non-Hodgkin Lymphoma in Pakistan Population: A Single-Center Study.

Cureus. 2023 Jan 28;15(1):e34298. doi: 10.7759/cureus.34298. eCollection 2023 Jan.

SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.

Mol Cancer. 2023 Feb 21;22(1):39. doi: 10.1186/s12943-023-01736-8.

本文引用的文献

Determinants of hospital death in haematological cancers: findings from a qualitative study.

BMJ Support Palliat Care. 2018 Mar;8(1):78-86. doi: 10.1136/bmjspcare-2016-001289. Epub 2017 Jun 29.

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.

Eur J Cancer. 2017 Jun;78:53-60. doi: 10.1016/j.ejca.2017.03.013. Epub 2017 Apr 13.

Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.

Br J Haematol. 2017 Apr;177(1):67-71. doi: 10.1111/bjh.14513. Epub 2017 Feb 1.

Phase-specific and lifetime costs of cancer care in Ontario, Canada.

BMC Cancer. 2016 Oct 18;16(1):809. doi: 10.1186/s12885-016-2835-7.

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.

Cancer Epidemiol. 2016 Jun;42:186-98. doi: 10.1016/j.canep.2016.03.011. Epub 2016 Apr 16.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.

Eur J Health Econ. 2017 Mar;18(2):255-267. doi: 10.1007/s10198-016-0775-4. Epub 2016 Mar 11.

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma.

Cancer Epidemiol. 2015 Dec;39(6):1103-12. doi: 10.1016/j.canep.2015.08.015. Epub 2015 Sep 2.

Preferred and actual place of death in haematological malignancy.

BMJ Support Palliat Care. 2017 Jun;7(2):150-157. doi: 10.1136/bmjspcare-2014-000793. Epub 2015 Jul 8.

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献